Biotricity, Inc. (BTCY)

1.2542 -0.0458 (-3.52%) As of 03:47PM EDT. Market open.

Biotricity, Inc.

203 Redwood Shores Parkway
Suite 600
Redwood City, CA 94065
United States
(800) 590-4155
https://www.biotricity.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 55

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Waqaas Al-Siddiq Ph.D.	Founder, President, CEO & Chairman	732k	N/A	1985
Mr. S. John Ayanoglou	Chief Financial Officer	305.75k	N/A	1967
Mr. Andy Wong	Vice President of Operations	N/A	N/A	N/A
Dr. George N. Nikopoulos	Director of Business Development	N/A	N/A	N/A
Mr. Matt Zabel	Vice President of Sales & Strategy	N/A	N/A	N/A
Mr. Amir Ali	Chief Development Officer	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Corporate Governance

Biotricity, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.